BioSpace News Archive

Nutex Health Inc. today announced the departure of Matthew Young, M.D. from the Company’s Board of Directors at the end of his one year term commitment and the election of Danniel Stites, M.D. to the Board.

Scilex Holding Company, a subsidiary of Sorrento Therapeutics, Inc., announced that the Company’s 2023 Annual Meeting of Stockholders that was scheduled to be held at 9:00 a.m. on Thursday, April 6, 2023, has been postponed to April 17, 2023 at 9:00 a.m.

Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”) announced today that the Singapore Health Sciences Authority (HSA) has accepted its New Drug Application (NDA) for Nefecon for the treatment of primary immunoglobulin A nephropathy (IgAN) in adults at risk of disease progression.

Applied BioMath (www.appliedbiomath.com) today announced the speaker lineup for their Quantitative Systems Pharmacology (QSP) Summit occurring Thursday, April 27, 2023 in South San Francisco, CA.

Kezar Life Sciences, Inc. announced that the Compensation Committee of the company’s Board of Directors granted six employees nonqualified stock options to purchase 232,000 shares of its common stock with an exercise price of $3.05 per share, which is equal to the closing price of Kezar’s common stock on April 3, 2023, the grant date of the awards.

The Food Allergy Institute announced that a peer reviewed paper authored by its founder Inderpal Randhawa, MD, has been published by the clinical journal PLOS ONE.

PROCEPT® BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the first quarter of 2023 before market open on Thursday, April 27, 2023.

– RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, announced plans to participate in the upcoming Needham Healthcare Conference.